This episode features Sam Jactel, Founder & CEO of Ayble Health. Here, he discusses his background & what motivated him to start Ayble Health, his top priorities going forward in 2023, trends he is watching in the GI space, and more.
Trending
- MicrobioTx launches finger prick-based test to profile gut microbiome (The Financial Express)
- Young Doctors Want Work-Life Balance. Older Doctors Say That’s Not the Job. (The Wall Street Journal)
- Sale of Steward’s doctors network is finalized, new owners rebrand as Revere Medical (WBUR)
- FDA Updates GLP-1 Label With Pulmonary Aspiration Warning (Medscape)
- Study Finds GLP-1s Safe and Effective For Managing Obesity in Patients With IBD (GI & Endoscopy News)
- Private equity in gastroenterology: 5 things to know (Becker’s GI & Endoscopy)
- How the healthcare industry is reacting to a second Trump term (Medtech Dive)
- Ozempic startup Yazen raises €19.5m Series A to combat obesity (Sifted)